RESULTS FOR : 'Radiochemistry'
Showing 1 to 2 of 2 results |    
Keyword Search
Results Category/Section
Carbon-14 Labelled API Manufacturing

Carbon-14 labelled API and IMP requirements for Phase 0/I to Phase III mass balance and micro-dosing clinical trials can be met by contract manufacturing in compliance with MHRA and FDA Phase I cGMP guidelines.

Custom Carbon-14 Radiolabelling: Investing to meet new challenges

One consequence of an increasing demand from regulators for robust quantitative data on the behaviour of new drugs in man and for information on the fate of pharmaceuticals in the environment, has been an increase in demand for carbon-14 labelled compounds.